Oxidative modifications of DAMPs suppress inflammation: The case for S100A8 and S100A9

Antioxidants and Redox Signaling

Volumn 15, Issue 8, 2011, Pages 2235-2248

  Lim, Su Yin ^a   Raftery, Mark J ^a   Geczy, Carolyn L ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CALGRANULIN A; CALGRANULIN B; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GALECTIN 1; GAMMA INTERFERON; GLUTAREDOXIN; GLUTATHIONE; HIGH MOBILITY GROUP B1 PROTEIN; HYDROXYL RADICAL; HYPOCHLORITE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; LOW DENSITY LIPOPROTEIN; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PROTEIN S 100; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SULFENIC ACID DERIVATIVE; THIOREDOXIN; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 6; TRANSCRIPTION FACTOR NRF2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNINDEXED DRUG;

ANTIINFLAMMATORY ACTIVITY; BONE MARROW CELL; CELL ACTIVATION; GENE CONTROL; HUMAN; INFLAMMATION; LEUKOCYTE ADHERENCE; MAST CELL; NITROSYLATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROCESSING; REVIEW; VASCULARIZATION;

ANIMALS; CALGRANULIN A; CALGRANULIN B; HUMANS; INFLAMMATION; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES;

EID: 80052560779     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2010.3641     Document Type: Review

References (90)

1. Aguiar-Passeti T, Postol E, Sorg C, and Mariano M. Epithelioid cells from foreign-body granuloma selectively express the calcium-binding protein MRP-14, a novel downregulatory molecule of macrophage activation. J Leukoc Biol 62: 852-858, 1997. (Pubitemid 28015634)
2. Bai B, Yamamoto K, Sato H, Sugiura H, and Tanaka T. Complex regulation of S100A8 by IL-17, dexamethasone, IL-4 and IL-13 in HaCat cells (human keratinocyte cell line). J Dermatol Sci 47: 259-262, 2007. (Pubitemid 47077902)
3. Barnham KJ, Masters CL, and Bush AI. Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 3: 205-214, 2004.
4. Benedyk M, Sopalla C, Nacken W, Bode G, Melkonyan H, Banfi B, and Kerkhoff C. HaCaT keratinocytes overexpressing the S100 proteins S100A8 and S100A9 show increased NADPH oxidase and NF-kappaB activities. J Invest Dermatol 127: 2001-2011, 2007. (Pubitemid 47075374)
5. Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 81: 1-5, 2007. (Pubitemid 46028489)
6. Biswas S, Chida AS, and Rahman I. Redox modifications of protein-thiols: emerging roles in cell signaling. Biochem Pharmacol 71: 551-564, 2006. (Pubitemid 43121989)
7. Bourdon E and Blache D. The importance of proteins in defense against oxidation. Antioxid Redox Signal 3: 293-311, 2001. (Pubitemid 32473344)
8. Boyd JH, Kan B, Roberts H, Wang Y, and Walley KR. S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products. Circ Res 102: 1239-1246, 2008.
9. Candiano G, Petretto A, Bruschi M, Santucci L, Dimuccio V, Prunotto M, Gusmano R, Urbani A, and Ghiggeri GM. The oxido-redox potential of albumin methodological approach and relevance to human diseases. J Proteom 73: 188-195, 2009.
10. Carta S, Castellani P, Delfino L, Tassi S, Vene R, and Rubartelli A. DAMPs and inflammatory processes: the role of redox in the different outcomes. J Leukoc Biol 86: 549-555, 2009.
11. Chapman AL, Skaff O, Senthilmohan R, Kettle AJ, and Davies MJ. Hypobromous acid and bromamine production by neutrophils and modulation by superoxide. Biochem J 417: 773-781, 2009.
12. Comhair SA and Erzurum SC. Redox control of asthma: molecular mechanisms and therapeutic opportunities. Antioxid Redox Signal 12: 93-124, 2010.
13. Corbin BD, Seeley EH, Raab A, Feldmann J, Miller MR, Torres VJ, Anderson KL, Dattilo BM, Dunman PM, Gerads R, Caprioli RM, Nacken W, Chazin WJ, and Skaar EP. Metal chelation and inhibition of bacterial growth in tissue abscesses. Science 319: 962-965, 2008. (Pubitemid 351263768)
14. Cornish CJ, Devery JM, Poronnik P, Lackmann M, Cook DI, and Geczy CL. S100 protein CP-10 stimulates myeloid cell chemotaxis without activation. J Cell Physiol 166: 427-437, 1996. (Pubitemid 26042420)
15. Dazard JE, Gal H, Amariglio N, Rechavi G, Domany E, and Givol D. Genome-wide comparison of human keratinocyte and squamous cell carcinoma responses to UVB irradiation: implications for skin and epithelial cancer. Oncogene 22: 2993-3006, 2003. (Pubitemid 36648927)
16. De Lorenzo BH, Godoy LC, Novaes EBRR, Pagano RL, Amorim-Dias MA, Grosso DM, Lopes JD, and Mariano M. Macrophage suppression following phagocytosis of apoptotic neutrophils is mediated by the S100A9 calciumbinding protein. Immunobiology 2009.
17. Devery JM, King NJ, and Geczy CL. Acute inflammatory activity of the S100 protein CP-10: activation of neutrophils in vivo and in vitro. J Immunol 152: 1888-1897, 1994. (Pubitemid 24075722)
18. Donato R. RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins. Curr Mol Med 7: 711-724, 2007.
19. Doussiere J, Bouzidi F, and Vignais PV. The S100A8=A9 protein as a partner for the cytosolic factors of NADPH oxidase activation in neutrophils. Eur J Biochem 269: 3246-3255, 2002. (Pubitemid 34748111)
20. Dumitriu IE, Baruah P, Manfredi AA, Bianchi ME, and Rovere-Querini P. HMGB1: guiding immunity from within. Trends Immunol 26: 381-387, 2005. (Pubitemid 40835844)
21. Ehrchen JM, Sunderkotter C, Foell D, Vogl T, and Roth J. The endogenous Toll-like receptor 4 agonist S100A8=S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J Leukoc Biol 86: 557-566, 2009.
22. El-Benna J, Dang PM, Gougerot-Pocidalo MA, and Elbim C. Phagocyte NADPH oxidase: a multicomponent enzyme essential for host defenses. Arch Immunol Ther Exp (Warsz) 53: 199-206, 2005. (Pubitemid 41059740)
23. Endoh Y, Chung YM, Clark IA, Geczy CL, and Hsu K. IL-10-dependent S100A8 gene induction in monocytes=macrophages by double-stranded RNA. J Immunol 182: 2258-2268, 2009.
24. Gaboury JP, Niu XF, and Kubes P. Nitric oxide inhibits numerous features of mast cell-induced inflammation. Circulation 93: 318-326, 1996. (Pubitemid 26031491)
25. Gallogly MM and Mieyal JJ. Mechanisms of reversible protein glutathionylation in redox signaling and oxidative stress. Curr Opin Pharmacol 7: 381-391, 2007. (Pubitemid 47304000)
26. Ghavami S, Chitayat S, Hashemi M, Eshraghi M, Chazin WJ, Halayko AJ, and Kerkhoff C. S100A8=A9: a Janus-faced molecule in cancer therapy and tumorgenesis. Eur J Pharmacol 625: 73-83, 2009.
27. Ghezzi P, Bonetto V, and Fratelli M. Thiol-disulfide balance: from the concept of oxidative stress to that of redox regulation. Antioxid Redox Signal 7: 964-972, 2005. (Pubitemid 40967147)
28. Grimbaldeston MA, Geczy CL, Tedla N, Finlay-Jones JJ, and Hart PH. S100A8 induction in keratinocytes by ultraviolet A irradiation is dependent on reactive oxygen intermediates. J Invest Dermatol 121: 1168-1174, 2003. (Pubitemid 37430989)
29. Harrison CA, Raftery MJ, Walsh J, Alewood P, Iismaa SE, Thliveris S, and Geczy CL. Oxidation regulates the inflammatory properties of the murine S100 protein S100A8. J Biol Chem 274: 8561-8569, 1999. (Pubitemid 29164647)
30. Hazell LJ, van den Berg JJ, and Stocker R. Oxidation of lowdensity lipoprotein by hypochlorite causes aggregation that is mediated by modification of lysine residues rather than lipid oxidation. Biochem J 302: 297-304, 1994. (Pubitemid 24256368)
31. Hess DT, Matsumoto A, Kim SO, Marshall HE, and Stamler JS. Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Biol 6: 150-166, 2005. (Pubitemid 40215810)
32. Hobbs JA, May R, Tanousis K, McNeill E, Mathies M, Gebhardt C, Henderson R, Robinson MJ, and Hogg N. Myeloid cell function in MRP-14 (S100A9) null mice. Mol Cell Biol 23: 2564-2576, 2003. (Pubitemid 36351035)
33. Hoppe G, Talcott KE, Bhattacharya SK, Crabb JW, and Sears JE. Molecular basis for the redox control of nuclear transport of the structural chromatin protein Hmgb1. Exp Cell Res 312: 3526-3538, 2006. (Pubitemid 44470773)
34. Hoshi T and Heinemann S. Regulation of cell function by methionine oxidation and reduction. J Physiol 531: 1-11, 2001. (Pubitemid 32178022)
35. Hsu K, Champaiboon C, Guenther BD, Sorenson BS, Khammanivong A, Ross KF, Geczy CL, and Herzberg MC. Anti-infective protective properties of S100 calgranulins. Anti-Inflammatory Anti-Allergy Agents Med Chem (Formerly Cu 8: 290-305, 2009.
36. Hsu K, Passey RJ, Endoh Y, Rahimi F, Youssef P, Yen T, and Geczy CL. Regulation of S100A8 by glucocorticoids. J Immunol 174: 2318-2326, 2005. (Pubitemid 40223981)
37. Hu SP, Harrison C, Xu K, Cornish CJ, and Geczy CL. Induction of the chemotactic S100 protein, CP-10, in monocyte= macrophages by lipopolysaccharide. Blood 87: 3919-3928, 1996. (Pubitemid 26130614)
38. Ikemoto M, Murayama H, Itoh H, Totani M, and Fujita M. Intrinsic function of S100A8=A9 complex as an antiinflammatory protein in liver injury induced by lipopolysaccharide in rats. Clin Chim Acta 376: 197-204, 2007. (Pubitemid 44881002)
39. Inagaki Y, Sohma Y, Horie H, Nozawa R, and Kadoya T. Oxidized galectin-1 promotes axonal regeneration in peripheral nerves but does not possess lectin properties. Eur J Biochem 267: 2955-2964, 2000. (Pubitemid 30321342)
40. Jaffrey SR, Erdjument-Bromage H, Ferris CD, Tempst P, and Snyder SH. Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat Cell Biol 3: 193-197, 2001. (Pubitemid 32118373)
41. Kazama H, Ricci JE, Herndon JM, Hoppe G, Green DR, and Ferguson TA. Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity 29: 21-32, 2008. (Pubitemid 351952462)
42. Kerkhoff C, Nacken W, Benedyk M, Dagher MC, Sopalla C, and Doussiere J. The arachidonic acid-binding protein S100A8=A9 promotes NADPH oxidase activation by interaction with p67phox and Rac-2. FASEB J 19: 467-469, 2005. (Pubitemid 40316552)
43. Kim J, Cha YN, and Surh YJ. A protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disorders. Mutat Res 2009.
44. Koppal T, Lam AG, Guo L, and Van Eldik LJ. S100B proteins that lack one or both cysteine residues can induce inflammatory responses in astrocytes and microglia. Neurochem Int 39: 401-407, 2001. (Pubitemid 32907404)
45. Kumar RK, Yang Z, Bilson S, Thliveris S, Cooke BE, and Geczy CL. Dimeric S100A8 in human neutrophils is diminished after phagocytosis. J Leukoc Biol 70: 59-64, 2001. (Pubitemid 32613663)
46. Kunsch C and Medford RM. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res 85: 753-766, 1999. (Pubitemid 29480816)
47. Lackmann M, Rajasekariah P, Iismaa SE, Jones G, Cornish CJ, Hu S, Simpson RJ, Moritz RL, and Geczy CL. Identification of a chemotactic domain of the pro-inflammatory S100 protein CP-10. J Immunol 150: 2981-2991, 1993. (Pubitemid 23127547)
48. Leach ST, Yang Z, Messina I, Song C, Geczy CL, Cunningham AM, and Day AS. Serum and mucosal S100 proteins, calprotectin (S100A8=S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease. Scand J Gastroenterol 42: 1321-1331, 2007. (Pubitemid 47537067)
49. Lee YS, Sohn KC, Jang S, Lee Y, Hwang C, Kim KH, Cho MJ, Kim CD, and Lee JH. Anti-apoptotic role of S100A8 in X-ray irradiated keratinocytes. J Dermatol Sci 51: 11-18, 2008.
50. Lim SY, Raftery M, Cai H, Hsu K, Yan WX, Hseih HL, Watts RN, Richardson D, Thomas S, Perry M, and Geczy CL. Snitrosylated S100A8: novel anti-inflammatory properties. J Immunol 181: 5627-5636, 2008.
51. Lim SY, Raftery MJ, Goyette J, and Geczy CL. S-glutathionylation regulates inflammatory activities of S100A9. J Biol Chem 285: 14377-14388, 2010.
52. Lim SY, Raftery MJ, Goyette J, Hsu K, and Geczy CL. Oxidative modifications of S100 proteins: functional regulation by redox. J Leukoc Biol 86: 577-587, 2009.
53. Lotze MT and Tracey KJ. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 5: 331-342, 2005. (Pubitemid 40516158)
54. McCormick MM, Rahimi F, Bobryshev YV, Gaus K, Zreiqat H, Cai H, Lord RS, and Geczy CL. S100A8 and S100A9 in human arterial wall: implications for atherogenesis. J Biol Chem 280: 41521-41529, 2005. (Pubitemid 41832213)
55. McMillen TS, Heinecke JW, and LeBoeuf RC. Expression of human myeloperoxidase by macrophages promotes atherosclerosis in mice. Circulation 111: 2798-2804, 2005. (Pubitemid 40791552)
56. Medzhitov R and Janeway CA Jr. Decoding the patterns of self and nonself by the innate immune system. Science 296: 298-300, 2002. (Pubitemid 34303673)
57. Nathan C and Xie QW. Regulation of biosynthesis of nitric oxide. J Biol Chem 269: 13725-13728, 1994. (Pubitemid 24191108)
58. Newton RA and Hogg N. The human S100 protein MRP-14 is a novel activator of the beta 2 integrin Mac-1 on neutrophils. J Immunol 160: 1427-1435, 1998. (Pubitemid 28093444)
59. Passey RJ, Williams E, Lichanska AM, Wells C, Hu S, Geczy CL, Little MH, and Hume DA. A null mutation in the inflammation-associated S100 protein S100A8 causes early resorption of the mouse embryo. J Immunol 163: 2209-2216, 1999. (Pubitemid 29382229)
60. Paul-Clark MJ, McMaster SK, Sorrentino R, Sriskandan S, Bailey LK, Moreno L, Ryffel B, Quesniaux VF, and Mitchell JA. Toll-like receptor 2 is essential for the sensing of oxidants during inflammation. Am J Respir Crit Care Med 179: 299-306, 2009.
61. Poole LB, Karplus PA, and Claiborne A. Protein sulfenic acids in redox signaling. Annu Rev Pharmacol Toxicol 44: 325-347, 2004. (Pubitemid 38263844)
62. Pouliot P, Plante I, Raquil MA, Tessier PA, and Olivier M. Myeloid-related proteins rapidly modulate macrophage nitric oxide production during innate immune response. J Immunol 181: 3595-3601, 2008.
63. Raftery MJ, Collinson L, and Geczy CL. Overexpression, oxidative refolding, and zinc binding of recombinant forms of the murine S100 protein MRP14 (S100A9). Protein Expr Purif 15: 228-235, 1999. (Pubitemid 29332258)
64. Raftery MJ and Geczy CL. Electrospray low energy CID and MALDI PSD fragmentations of protonated sulfinamide cross-linked peptides. J Am Soc Mass Spectrom 13: 709-718, 2002. (Pubitemid 36876024)
65. Raftery MJ, Yang Z, Valenzuela SM, and Geczy CL. Novel intra-and inter-molecular sulfinamide bonds in S100A8 produced by hypochlorite oxidation. J Biol Chem 276: 33393-33401, 2001.
66. Rahimi F, Hsu K, Endoh Y, and Geczy CL. FGF-2, IL-1beta and TGF-beta regulate fibroblast expression of S100A8. FEBS J 272: 2811-2827, 2005. (Pubitemid 40825427)
67. Rammes A, Roth J, Goebeler M, Klempt M, Hartmann M, and Sorg C. Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J Biol Chem 272: 9496-9502, 1997. (Pubitemid 27154966)
68. Ravasi T, Hsu K, Goyette J, Schroder K, Yang Z, Rahimi F, Miranda LP, Alewood PF, Hume DA, and Geczy C. Probing the S100 protein family through genomic and functional analysis. Genomics 84: 10-22, 2004. (Pubitemid 38760126)
69. Robinson MJ, Tessier P, Poulsom R, and Hogg N. The S100 family heterodimer, MRP-8=14, binds with high affinity to heparin and heparan sulfate glycosaminoglycans on endothelial cells. J Biol Chem 277: 3658-3665, 2002. (Pubitemid 34953239)
70. Rothermundt M, Peters M, Prehn JH, and Arolt V. S100B in brain damage and neurodegeneration. Microsc Res Tech 60: 614-632, 2003.
71. Ryckman C, Vandal K, Rouleau P, Talbot M, and Tessier PA. Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8=A9 induce neutrophil chemotaxis and adhesion. J Immunol 170: 3233-3242, 2003. (Pubitemid 36302201)
72. Salama I, Malone PS, Mihaimeed F, and Jones JL. A review of the S100 proteins in cancer. Eur J Surg Oncol 34: 357-364, 2008. (Pubitemid 351381290)
73. Sato S, St-Pierre C, Bhaumik P, and Nieminen J. Galectins in innate immunity: dual functions of host soluble betagalactoside-binding lectins as damage-associated molecular patterns (DAMPs) and as receptors for pathogen-associated molecular patterns (PAMPs). Immunol Rev 230: 172-187, 2009.
74. Scotto C, Mely Y, Ohshima H, Garin J, Cochet C, Chambaz E, and Baudier J. Cysteine oxidation in the mitogenic S100B protein leads to changes in phosphorylation by catalytic CKII-alpha subunit. J Biol Chem 273: 3901-3908, 1998. (Pubitemid 28103248)
75. Shepherd CE, Goyette J, Utter V, Rahimi F, Yang Z, Geczy CL, and Halliday GM. Inflammatory S100A9 and S100A12 proteins in Alzheimer's disease. Neurobiol Aging 27: 1554-1563, 2006. (Pubitemid 44344843)
76. Shibata F, Ito A, Ohkuma Y, and Mitsui K. Mitogenic activity of S100A9 (MRP-14). Biol Pharm Bull 28: 2312-2314, 2005. (Pubitemid 41757426)
77. Sroussi HY, Berline J, Dazin P, Green P, and Palefsky JM. S100A8 triggers oxidation-sensitive repulsion of neutrophils. J Dent Res 85: 829-833, 2006. (Pubitemid 44409033)
78. Sroussi HY, Berline J, and Palefsky JM. Oxidation of methionine 63 and 83 regulates the effect of S100A9 on the migration of neutrophils in vitro. J Leukoc Biol 81: 818-824, 2007. (Pubitemid 46393560)
79. Sroussi HY, Kohler GA, Agabian N, Villines D, and Palefsky JM. Substitution of methionine 63 or 83 in S100A9 and cysteine 42 in S100A8 abrogate the antifungal activities of S100A8=A9: potential role for oxidative regulation. FEMS Immunol Med Microbiol 55: 55-61, 2009.
80. Sroussi HY, Lu Y, Zhang QL, Villines D, and Marucha PT. S100A8 and S100A9 inhibit neutrophil oxidative metabolism in-vitro: Involvement of adenosine metabolites. Free Radic Res 44: 389-396, 2010.
81. Sroussi HY, Williams RL, Zhang QL, Villines D, and Marucha PT. Ala42S100A8 ameliorates psychological-stress impaired cutaneous wound healing. Brain Behav Immun 23: 755-759, 2009.
82. Turovskaya O, Foell D, Sinha P, Vogl T, Newlin R, Nayak J, Nguyen M, Olsson A, Nawroth PP, Bierhaus A, Varki N, Kronenberg M, Freeze HH, and Srikrishna G. RAGE, carboxylated glycans and S100A8=A9 play essential roles in colitis-associated carcinogenesis. Carcinogenesis 29: 2035-2043, 2008.
83. Viemann D, Strey A, Janning A, Jurk K, Klimmek K, Vogl T, Hirono K, Ichida F, Foell D, Kehrel B, Gerke V, Sorg C, and Roth J. Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells. Blood 105: 2955-2962, 2005. (Pubitemid 40446292)
84. Vogl T, Roth J, Sorg C, Hillenkamp F, and Strupat K. Calcium-induced noncovalently linked tetramers of MRP8 and MRP14 detected by ultraviolet matrix-assisted laser desorption=ionization mass spectrometry. J Am Soc Mass Spectrom 10: 1124-1130, 1999. (Pubitemid 34498669)
85. Vogl T, Tenbrock K, Ludwig S, Leukert N, Ehrhardt C, van Zoelen MA, Nacken W, Foell D, van der Poll T, Sorg C, and Roth J. Mrp8 and Mrp14 are endogenous activators of Tolllike receptor 4, promoting lethal, endotoxin-induced shock. Nat Med 13: 1042-1049, 2007. (Pubitemid 47517513)
86. Wu Z, Hoover DM, Yang D, Boulegue C, Santamaria F, Oppenheim JJ, Lubkowski J, and Lu W. Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3. Proc Natl Acad Sci USA 100: 8880-8885, 2003. (Pubitemid 36899192)
87. Xu K, Yen T, and Geczy CL. Il-10 up-regulates macrophage expression of the S100 protein S100A8. J Immunol 166: 6358-6366, 2001. (Pubitemid 32440769)
88. Yan WX, Armishaw C, Goyette J, Yang Z, Cai H, Alewood P, and Geczy CL.Mast cell and monocyte recruitment by S100A12 and its hinge domain. J Biol Chem 283: 13035-13043, 2008.
89. Yang H, Hreggvidsdottir HS, Palmblad K, Wang H, Ochani M, Li J, Lu B, Chavan S, Rosas-Ballina M, Al-Abed Y, Akira S, Bierhaus A, Erlandsson-Harris H, Andersson U, and Tracey KJ. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc Natl Acad Sci USA 2010.
90. Yen T, Harrison CA, Devery JM, Leong S, Iismaa SE, Yoshimura T, and Geczy CL. Induction of the S100 chemotactic protein, CP-10, in murine microvascular endothelial cells by proinflammatory stimuli. Blood 90: 4812-4821, 1997. (Pubitemid 28007195)